SALT trial. Author's repliesGOSSMANN, J; NORRVING, B; JAMIESON, C et al.Lancet (British edition). 1992, Vol 339, Num 8789, issn 0140-6736, p. 377Article

Aspirin metabolites causing misinterpretation of paracetamol resultsBADCOCK, N. R; PENNA, A. C; EVERETT, D. S et al.Annals of clinical biochemistry. 1984, Vol 21, Num 6, pp 527-530, issn 0004-5632Article

Amplification of primary response of human platelets to platelet-activating factor: aspirin-sensitive and aspirin-insensitive pathwaysLAURI, D; CERLETTI, C; DE GAETANO, G et al.The Journal of laboratory and clinical medicine. 1985, Vol 105, Num 6, pp 653-658, issn 0022-2143Article

Aspirin in acute gastroenteritis: a clinical and microbiological studyGRACEY, M; PHADKE, M. A; BURKE, V et al.Journal of pediatric gastroenterology and nutrition. 1984, Vol 3, Num 5, pp 692-695, issn 0277-2116Article

Reduction of aspirin-induced fecal blood loss with low-dose misoprostol tablets in manCOHEN, M. M; CLARK, L; ARMSTRONG, L et al.Digestive diseases and sciences. 1985, Vol 30, Num 7, pp 605-611, issn 0163-2116Article

Revised method for determination of aspirin and salicylic acid in human plasma by high pressure liquid chromatographyMASON, W. D; GILLILAN, R.Analytical letters. 1983, Vol 16, Num 12, pp 903-912, issn 0003-2719Article

Aspirin inhibits vascular plasminogen activator activity in vivo: studies utilizing a new assay to quantity plasminogen activator activityLEVIN, R. I; HARPEL, P. C; WEIL, D et al.The Journal of clinical investigation. 1984, Vol 74, Num 2, pp 571-580, issn 0021-9738Article

Prevention of the inhibitory effects of aspirin on sodium transport in canine gastric mucosa by prostaglandinMILLER, T. A; SCHMIDT, K. L; HENAGAN, J. M et al.The Journal of surgical research. 1984, Vol 36, Num 4, pp 315-326, issn 0022-4804Conference Paper

Effect of aspirin on determinations of glycosylated hemoglobinNATHAN, D. M; FRANCIS, T. B; PALMER, J. L et al.Clinical chemistry (Baltimore, Md.). 1983, Vol 29, Num 3, pp 466-469, issn 0009-9147Article

The absence of detectable complement activation in aspirin-sensitive asthmatic patients during aspirin challengePLESKOW, W. W; CHENOWETH, D. E; SIMON, R. A et al.Journal of allergy and clinical immunology. 1983, Vol 72, Num 5, pp 462-468, issn 0091-6749Article

Spectrophotometric determination of aspirin by transacetylation of 4-aminophenolVERMA, K. K; JAIN, A.Analytical chemistry (Washington, DC). 1986, Vol 58, Num 4, pp 821-824, issn 0003-2700Article

Possible low-dose-aspirin-induced gastropathyBAKER, P. N; WILLIAMSON, J. G; LOUDEN, K. A et al.Lancet (British edition). 1992, Vol 339, Num 8792, issn 0140-6736, p. 550Article

Low-dose aspirin and nulliparaeBREART, G; BEAUFILS, M; UZAN, S et al.Lancet (British edition). 1991, Vol 338, Num 8771, issn 0140-6736, p. 892Article

Disintegrating force as a new formulation parameterCOLOMBO, P; CONTE, U; CARAMELLA, C et al.Journal of pharmaceutical sciences. 1984, Vol 73, Num 5, pp 701-705, issn 0022-3549Article

Thrombelastography in pregnant patients on low-dose aspirinORLIKOWSKI, C. E. P; MOODLEY, J; ROCKE, D. A et al.Lancet (British edition). 1991, Vol 338, Num 8777, pp 1276-1277, issn 0140-6736Article

Les médicaments de la douleur = Analgesic agentsESCHALIER, A; AUMAITRE, O; DORDAIN, G et al.Concours médical (Paris). 1987, Vol 109, Num 16, pp 1455-1459, issn 0010-5309Article

Pharmacologie des médicaments antiagrégants = Pharmacology of antiplatelet drugsDE GAETANO, G; CERLETTI, C.Entretiens du Carla (Les). 1985, Vol 4, pp 45-55Article

Stabilized normal-phase high-performance liquid chromatographic analysis of aspirin and salicylic acid in solid pharmaceutical dosage formsGALANTE, R. N; VISALLI, A. J; GRIM, W. M et al.Journal of pharmaceutical sciences. 1984, Vol 73, Num 2, pp 195-197, issn 0022-3549Article

Epinephrine-induced reversal of aspirin effects on platelet deformabilitySMITH, C. M. II; BURRIS, S. M; RAO, G. H. R et al.Thrombosis research. 1988, Vol 51, Num 1, pp 35-44, issn 0049-3848Article

Differential effects of aspirin and indomethacin on platelet and leukocyte thromboxane A₂ formationMADERNA, P; COLLI, S; MORAZZONI, G et al.Prostaglandins leukotrienes and medicine. 1985, Vol 18, Num 3, pp 379-391, issn 0262-1746Article

Diffusion de l'aspirine et de ses métabolites à travers la membrane synoviale = Distribution of aspirin and metabolites in synovial membraneBANNWARTH, B; NETTER, P; POUREL, J et al.Revue du rhumatisme et des maladies ostéo-articulaires. 1985, Vol 52, Num 5, pp 333-336, issn 0035-2659Article

The effect of film-inducing substances on the characteristics of binary powder mixturesSAMAHA, M. W; EL GINDY, N. A.International journal of pharmaceutics. 1984, Vol 19, Num 1, pp 63-74, issn 0378-5173Article

Monitoring the entry of new platelets into the circulation after ingestion of aspirinDI MINNO, G; SILVER, M. J; MURPHY, S et al.Blood. 1983, Vol 61, Num 6, pp 1081-1085, issn 0006-4971Article

A stability study of 3,5-diiodoaspirin in aqueous solutionTAYLOR, R. B; DURHAM, D. G; SHIVJI, A. S. H et al.Acta pharmaceutica suecica. 1986, Vol 23, Num 5, pp 295-300, issn 0001-6675Article

ASPIRIN TREATMENT OF MIGRAINE ATTACKS: CLINICAL OBSERVATIONSROSS LEE L; EADIE MJ; TYRER JH et al.1982; CEPHALALGIA; ISSN 505293; NOR; DA. 1982; VOL. 2; NO 2; PP. 71-76; BIBL. 4 REF.Article